Aileron Therapeutics Inc (ALRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 6,071 | 9,039 | 7,205 | 7,290 | 1,983 |
| Operating Income | -6,071 | -9,039 | -7,205 | -7,290 | -1,983 |
| Other Income | 224 | 97 | 92 | -49 | 156 |
| Pre-tax Income | -5,847 | -8,942 | -7,113 | -7,339 | -1,827 |
| Net Income Continuous | -5,847 | -8,942 | -7,113 | -7,339 | -1,827 |
| Net Income | $-5,847 | $-8,942 | $-7,113 | $-7,339 | $-1,827 |
| EPS Basic Total Ops | -0.27 | -0.45 | -0.86 | -1.58 | -0.40 |
| EPS Basic Continuous Ops | -0.27 | -0.45 | -0.86 | -1.57 | -0.40 |
| EPS Diluted Total Ops | -0.27 | -0.45 | -0.86 | -1.58 | -0.40 |
| EPS Diluted Continuous Ops | -0.27 | -0.45 | -0.86 | -1.57 | -0.40 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.45 | -0.86 | -1.54 | -0.40 |
| EBITDA(a) | $-6,071 | $-9,035 | $-7,146 | $-7,050 | $-1,972 |